CYP19A1 and cancer: The reduction in oestrogen-sensitive cancers is consistent with other systematic reviews [105,107,108] and is most likely related to the reduction in aromatase activity, plasma and tissue oestrogen and serum leptin and insulin following bariatric surgery [109,110].